USPTO serial 97748043
Q-LINEA
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- ROSEN, BENJAMIN H
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with Q-LINEA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,444*
Plus Government fees of $750
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donna J. Bunton
Donna J. Bunton NIXON & VANDERHYE P.C.901 NORTH GLEBE ROAD, 11TH FLOORARLINGTON, VA 22203United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific or research use; diagnostic preparations for scientific or research use other than for medical use; nucleic acids; nucleic acid for use in nucleic acid amplification processes other than for medical use; nucleic acid amplification reagents other than for medical use; nucleic acid sequencing programs other than for medical use; nucleic acid sequences, other than for medical or veterinary purposes; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria; diagnostic preparations for scientific purposes; diagnostic preparations, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Diagnostic preparations for veterinary purposes; medical diagnostic reagents; clinical diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical purposes | ACTIVE | — |
| 009 | Scientific apparatus for detecting, identifying and analysing pathogens and infectious agents, and for microbial identification and antibiotic resistance marker mapping, all the aforesaid, for laboratory or medical research purposes; Scientific instruments for microbial identification and antibiotic resistance marker mapping; laboratory instruments for the detection of pathogens and toxins in a biological sample for research use; diagnostic apparatus, not for medical purposes, for the detection and identification of pathogens for laboratory or research purposes; software for use in protein and nucleic acid analysis, micro-organism detection and identification, and in vitro diagnostics; downloadable computer operating system software; detection apparatus, namely, medical laboratory research apparatus for detecting pathogens or infectious agents; diagnostic apparatus, namely, fluorescence detectors; measuring instruments for measuring and quantifying DNA sequences; measuring apparatus for measuring and quantifying DNA sequences; testing apparatus for diagnostic purposes other than medical and veterinary use, namely, apparatus for testing antibiotic susceptibility of pathogens | ACTIVE | — |
| 010 | Medical diagnostic apparatus for the detection of abnormal prion protein; medical apparatus, namely, testing apparatus for analyzing bacteria in biological samples for medical use; medical diagnostic instruments for the detection and identification of pathogens or infectious agents; medical diagnostic apparatus for the detection and identification of pathogens or infectious agents; testing instruments for medical diagnostic purposes, for testing blood and other bodily fluids and biological samples; testing apparatus for testing blood and other bodily fluids and biological samples for medical and veterinary use | ACTIVE | — |
| 042 | Scientific analysis in the field of molecular biology; scientific research relating to molecular sciences; technological research relating to protein and nucleic acid analysis, microorganism detection and identification, in vitro diagnostics, the detection, identification and analysis of pathogens and infectious agents, the antibiotic susceptibility of pathogens, microbial identification and antibiotic resistance marker mapping; technological scientific studies relating to protein and nucleic acid analysis, micro- organism detection and identification, in vitro diagnostics, the detection, identification and analysis of pathogens and infectious agents, the antibiotic susceptibility of pathogens, microbial identification and antibiotic resistance marker mapping; technological scientific consultancy relating to protein and nucleic acid analysis, micro-organism detection and identification, in vitro diagnostics, the detection, identification and analysis of pathogens and infectious agents, the antibiotic susceptibility of pathogens, microbial identification and antibiotic resistance marker mapping; scientific and scientific technological services, namely, protein and nucleic acid analysis, micro-organism detection and identification, in vitro diagnostics, the detection, identification and analysis of pathogens and infectious agents, analysing and testing the antibiotic susceptibility of pathogens, microbial identification, and antibiotic resistance marker mapping; scientific consultancy and research services in the fields of science, engineering and information technology; provision of scientific information and data relating to scientific and technological research and development; research and development services in the field of bacteriology, cytology, antibody technology, chemistry, immunology and gene expression systems; scientific research; scientific research consultancy; scientific analysis in the field of molecular biology; scientific research services; scientific laboratory services; scientific genetic testing for scientific research purposes; scientific technological advisory services related to molecular biology and molecular sciences; compilation of scientific information; preparation of scientific reports for scientific analysis purposes; scientific research and development; conducting of scientific studies in the field of medicine; conducting of scientific experiments relating to pharmaceuticals; scientific research relating to bacteriology; scientific research relating to biology; scientific research in the field of genetics and genetic engineering; design and development of diagnostic apparatus; research and development in the field of diagnostic preparations; biotechnology testing relating to DNA for scientific research purposes; microbiological testing for scientific research purposes; bacteriological research and testing for scientific research purposes; analytical services relating to the testing of the bacterial content of liquids for scientific research purposes; medical testing for research purposes | ACTIVE | — |
| 044 | Rental of medical equipment; consultancy services in the fields of medical and orthopaedic surgery; consultancy services in the fields of medical diagnostic testing, monitoring and reporting services, namely, protein and nucleic acid analysis, micro-organism detection and identification, in vitro diagnostics, detection, identification and analysis of pathogens and infectious agents, antibiotic susceptibility of pathogens, microbial identification, and antibiotic resistance marker mapping, all for the diagnostic treatment of patients; Medical diagnostic testing, monitoring and reporting services; surgical diagnostic services being medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic and treatment purposes, medical services for the testing of blood; medical services for the testing of sera; medical and healthcare services in the fields of DNA, genetics and genetic testing; medical testing services relating to the diagnosis and treatment of disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Q-linea AB
- Other trademarks owned by Q-linea AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named Q-LINEA
- Prosecution event EEXT explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 17, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 16, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Apr 16, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Apr 16, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 14, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 14, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 14, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 14, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 14, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 14, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 30, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 30, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 30, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 30, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 16, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 4, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 1, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 31, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 11, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 10, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 11, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 11, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 11, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 3, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 31, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 13, 2023 | NWAP | NEW APPLICATION ENTERED | — |